Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

× No keyword cloud information.

8 in total

1. Osteoprotegerin is not associated with angiographic coronary calcification.

Authors: Prospero B Gogo; David J Schneider; Edward F Terrien; Burton E Sobel; Harold L Dauerman
Journal: J Thromb Thrombolysis Date: 2006-12 Impact factor: 2.300

2. Increased local cytokine production at culprit superficial femoral artery plaques.

Authors: Cameron W Donaldson; David J Schneider; Daniel J Bertges; Julie E Adams; Nader Z Elgharib; Enkhtuyaa L Mueller; William Prabhu; Taka Ashikaga; Harold L Dauerman
Journal: J Thromb Thrombolysis Date: 2013-10 Impact factor: 2.300

Review 3. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Authors: Monique P Curran; Gillian M Keating
Journal: Drugs Date: 2005 Impact factor: 9.546

4. Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.

Authors: Alexey A Mazaev; Yaroslav A Naimushin; Valery P Masenko; Mikhail Y Ruda; Alexey V Mazurov
Journal: J Thromb Thrombolysis Date: 2007-12-28 Impact factor: 2.300

8. Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study.

Authors: Boris Schnorbus; Andreas Daiber; Kerstin Jurk; Silke Warnke; Jochem König; Ulrike Krahn; Karl Lackner; Thomas Munzel; Tommaso Gori
Journal: BMJ Open Date: 2014-05-06 Impact factor: 2.692

8 in total

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

1. Osteoprotegerin is not associated with angiographic coronary calcification.

2. Increased local cytokine production at culprit superficial femoral artery plaques.

Review 3. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

4. Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.

5. Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Review 6. Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

7. A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

8. Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study.